Shivom: Genetic information at your fingertips
Shivom is a revolutionary project that is aimed at storing genetic information and sharing personal data with concern about ethics and efficiency. The platform promises to become a groundbreaking solution for medical corporations and scientists being based on the blockchain. The project is to be launched after the token sale and has already attracted the attention of millions of users.
What is Shivom created for?
Genomic medicine is among the most prospective areas: advances in genetics can help humanity to improve overall health, prolong life, and invent new ways of treatment of cancer, infections, cardiovascular problems, and thousands of other diseases. At the same time, blockchain technology transforms all spheres of our life, and medicine isn’t an exception. Shivom project was designed to unite blockchain and modern genomic medicine to generate a unique genomics ecosystem that will drive the development of healthcare.
To be more precise, Shivom will become the first blockchain platforms for genome data donors: the information about their genomes will be sequenced and stored in a secure database. Contributors will be rewarded by Omx token for sharing the information about their genetics. Yet, they can be sure in security and privacy – the data won’t be revealed to third parties without their consent. The platform will serve as an open marketplace for the organizations that need genetic data (governments, drugstores, research groups, universities, groups for patient support, and insurance companies). The information can be used for personalized medicine, analysis, and services.
The information obtained via Shivom can be used for:
- clinical research;
- drug development;
- precise identification of diseases;
- prognosis of disease;
- personal treatment.
Users of Shivom project
Theoretically, any user can store genetic data in Shivom platform, but it will be particularly useful for patients seeking specialized medical help. The organizations and doctors researching genetic data can help Shivom users to cure diseases and elaborate personalized treatment plans based on peculiarities of their genetics.
At the same time, scientists and universities will also benefit from the project. Imagine how much genetic information is required for fully-fledged research: it’s not always available in required volumes, but Shivom will give organizations access to genetic data. Therefore, Shivom unites insurance companies, pharmaceutical enterprises, and biotech companies and data donors in one environment.
Technical realization
Shivom is a web-based project that’s developed on the blockchain. That allows eliminating trust issues, problems with data correctness and integrity, patients’ consent, ownership of information, and authentication. Besides, smart contracts will be integrated into the process of data acquisition and transfer. The users who contribute their genetic information can be sure in safety of information: a key generator will create a pair of keys with the help of a cryptographic algorithm. User’s public key will stay encrypted. Only the keepers of the private key can access user’s genetic information (only after receiving his or her consent), and owners of data are free to decide who can get the data.
Together with a genetic data-hub, Shivom team will also found a non-profit medicine organization for precise diagnosis and treatment. Company’s researchers will apply data-driven techniques and instruments for the development of medicine and improvement of the healthcare system. The platform will out focus on artificial intelligence.
Shivom team
The international team behind Shivom is unique in its own way: it consists of experts in genetics and genomics, as well as specialists in the sphere of blockchain and IT technologies. Their vision and rich experience allow combining the recent advances in genetics, blockchain technology, and decentralized economy to create a groundbreaking project that can change the future of global healthcare system. The team works with well-known advisors and partners with world-leading investment companies and medicine-related foundations.
ICO Information
OmiX tokens will be used to pay for all services in Shivom platform: buying sequencing kits, sponsoring projects, getting data from the genome database, paying donors, and so on.
The main sale starts on April 16th, 2018: the team’s emitted 3,000,000,000 tokens, and 33% of them (990 mln) will be available for sale. The crowdfunding goal is $37,800,000 (75,000 Ethers), cost of 1 OmiX token is 0.0722 USD. ETH, BTC, and USD are accepted for payment, which is convenient for contributors who don’t own a crypto wallet. There is no minimal and maximum personal cap, which is both inconvenient and makes prediction of ICO campaign harder. However, the absence of limits makes Shivom suitable for minor and deep-pocketed investors.
Distribution of tokens
The numbers below are the number of OmiX tokens:
- 990 mln – sale during ICO;
- 90 mln – development and growth of Shivom, bounty, rewards;
- 420 mln – founders;
- 300 mln – advisors and early backers;
- 600 mln – secured by smart contract, used as rewards for data generation;
- 600 mln – reserve for data contribution.
The proceeds will be used for:
- Platform development – 20%;
- Business and operations- 11%;
- Non-profit platform – 10%;
- Marketing and formation of partnership – 21%;
- Legal questions and regulations – 5%;
- Laboratories – 25%;
- Data storage- 6%.
Besides, the rest 2% will be invested in launching sequencing in Indian hospitals.
Bottom line
Shivom is a revolutionary project that can change the development of genetic medicine for the better. Although the crowdfunding goal seems to be easy to achieve, the absence of minimal and maximum personal cap complicates the things. The cost of one OmiX token is pretty low, which is why the project can attract a lot of investors and get enough resources to be developed to a full extent.
Web * Whitepaper * Telegram * [ANN]Bitcointalk * [Bounty]Bitcointalk * Profile